Literature DB >> 10408810

Involvement of oxidative stress on the impairment of energy metabolism induced by A beta peptides on PC12 cells: protection by antioxidants.

C Pereira1, M S Santos, C Oliveira.   

Abstract

Alzheimer's disease is widely held to be associated with oxidative stress due, in part, to the membrane action of amyloid beta-peptide (A beta) aggregates. In this study, the involvement of oxidative stress on A beta-induced energy metabolism dysfunction was evaluated on PC12 cells. It was shown that A beta peptides (A beta25-35 and A beta1-40) induce a concentration-dependent accumulation of reactive oxygen species (ROS), decrease the cellular redox activity, and lead to the depletion of ATP levels. The observed inhibition by A beta of mitochondrial function and of glycolysis is blocked by the antioxidants vitamin E, idebenone, and GSH ethyl ester. Taken together, these data suggest that exposure of PC12 cells to A beta results in an impairment of energy metabolism, leading to a deficit in ATP levels and to the compromise of cellular viability. Furthermore, the generation of ROS seems to be a crucial event responsible for the energetic metabolic dysfunction induced by A beta.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10408810     DOI: 10.1006/nbdi.1999.0241

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  32 in total

1.  Dactylorhin B reduces toxic effects of beta-amyloid fragment (25-35) on neuron cells and isolated rat brain mitochondria.

Authors:  Dan Zhang; Yi Zhang; Gengtao Liu; Jianjun Zhang
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-10-05       Impact factor: 3.000

Review 2.  Molecular and biochemical trajectories from diabetes to Alzheimer's disease: A critical appraisal.

Authors:  Rajat Sandhir; Smriti Gupta
Journal:  World J Diabetes       Date:  2015-09-25

3.  The metabolic enhancer piracetam ameliorates the impairment of mitochondrial function and neurite outgrowth induced by beta-amyloid peptide.

Authors:  C Kurz; I Ungerer; U Lipka; S Kirr; T Schütt; A Eckert; K Leuner; W E Müller
Journal:  Br J Pharmacol       Date:  2010-03-09       Impact factor: 8.739

4.  The protective role of DL-alpha-lipoic acid in the oxidative vulnerability triggered by Abeta-amyloid vaccination in mice.

Authors:  E Philip Jesudason; J Gunasingh Masilamoni; K Samuel Jesudoss; R Jayakumar
Journal:  Mol Cell Biochem       Date:  2005-02       Impact factor: 3.396

Review 5.  Mitochondrial approaches for neuroprotection.

Authors:  Rajnish K Chaturvedi; M Flint Beal
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

Review 6.  Amyloid beta-protein assembly as a therapeutic target of Alzheimer's disease.

Authors:  Ghiam Yamin; Kenjiro Ono; Mohammed Inayathullah; David B Teplow
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

7.  Neuroprotective properties of Valeriana officinalis extracts.

Authors:  João O Malva; Sandra Santos; Tice Macedo
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

8.  Neuroprotective effect of H. perforatum extracts on beta-amyloid-induced neurotoxicity.

Authors:  Bruno A Silva; Alberto C P Dias; Federico Ferreres; João O Malva; Catarina R Oliveira
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

9.  Cholesterol potentiates beta-amyloid-induced toxicity in human neuroblastoma cells: involvement of oxidative stress.

Authors:  Patricia Ferrera; Octavio Mercado-Gómez; Martín Silva-Aguilar; Mahara Valverde; Clorinda Arias
Journal:  Neurochem Res       Date:  2008-02-21       Impact factor: 3.996

10.  Activation of PERK signaling attenuates Abeta-mediated ER stress.

Authors:  Do Yeon Lee; Kyu-Sun Lee; Hyun Jung Lee; Do Hee Kim; Yoo Hun Noh; Kweon Yu; Hee-Yeon Jung; Sang Hyung Lee; Jun Young Lee; Young Chul Youn; Yoonhwa Jeong; Dae Kyong Kim; Won Bok Lee; Sung Su Kim
Journal:  PLoS One       Date:  2010-05-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.